Capricor Therapeutics reported $1.59M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Bluebird Bio BLUE:US USD 71K 1.45M
Cytokinetics CYTK:US USD 2.51M 86.45M
Geron GERN:US USD 297K 224K
Johnson & Johnson JNJ:US USD 23.71B 85M
Newlink Genetics NLNK:US USD 497K 94K
Prothena PRTA:US USD 1.52M 205K
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Vascular Biogenics VBLT:US USD 481K 417K